Skip to main content

Table 3 Multivariate model to predict DFS and OS in patients after potentially curative liver metastasectomy

From: Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

Features

DFS

OS

HR (95% CI)

P value

HR (95% CI)

P value

CDX2 expression

 High

1 (reference)

 

1 (reference)

 

 Low

1.64 (1.08–2.38)

0.02

2.41 (1.52–3.85)

< 0.001

Sex

 Female

1 (reference)

 

1 (reference)

 

 Male

0.96 (0.73–1.24)

0.74

0.94 (0.65–1.34)

0.74

Tumor grade

 Well

1 (reference)

 

1 (reference)

 

 Mod

1.04 (0.73–1.47)

0.83

1.29 (0.79–2.10)

0.30

 Por

1.24 (0.68–2.28)

0.48

1.73 (0.73–4.04)

0.21

Pre- or post-operative chemotherapy

 No

1 (reference)

 

1 (reference)

 

 Yes

0.92 (0.68–1.22)

0.55

1.58 (1.06–2.36)

0.02

Tumor location

 Right

1 (reference)

 

1 (reference)

 

 Left

0.85 (0.62–1.17)

0.33

0.67 (0.44–1.01)

0.06

 Rectum

0.97 (0.71–1.37)

0.97

0.63 (0.68–1.05)

0.08

Liver metastasis

 Synchronous

1 (reference)

 

1 (reference)

 

 Metachronous

0.59 (0.45–0.77)

< 0.001

1.25 (0.88–1.79)

0.20

  1. Abbreviations: well Well differentiated, mod Moderately differentiated, por Poorly differentiated, HR Hazard ratio, OS Overall survival, DFS Disease-free survival